-
The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company.
02.02.2016 | MarketsandMarkets™
-
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
02.02.2016 | MarketsandMarkets™
-
The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type.
02.02.2016 | MarketsandMarkets™
-
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
02.02.2016 | MarketsandMarkets™
-
GlobalDatas epidemiological analysis provides a country-specific forecast for the diagnosed prevalent cases of GAD in the 8MM during 2014-2024.
01.02.2016 | MarketsandMarkets™
-
This report provides an overview of the risk factors, comorbidities, as well as the global and historical epidemiological trends for DES .
01.02.2016 | MarketsandMarkets™
-
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development.
01.02.2016 | MarketsandMarkets™
-
The report reviews the major players involved in the development of Vagus Nerve Stimulators and list all their pipeline projects.
01.02.2016 | MarketsandMarkets™
-
The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress.
01.02.2016 | MarketsandMarkets™
-
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.
01.02.2016 | MarketsandMarkets™
27470274682745927445274172741327394273522735127348